Congress Passes $91 Million Boost For FDA, And Releases Sequestered 2013 User Fees
This article was originally published in The Gray Sheet
A 2014 omnibus appropriations bill passed by the House Jan. 15 and the Senate a day later would give FDA $2.55 billion in discretionary funding, a $91 million increase. In news applauded by the device industry, the bill would also make available $85 million in previously sequestered FDA user fees. President Obama was expected to quickly sign the bill before a Jan. 18 midnight deadline to prevent a government shutdown.
You may also be interested in...
As the partial US government shutdown enters its second month, the backlog of device pre-market applications is building. AdvaMed is proposing language that would allow FDA to accept and review new user-fee-funded submissions during government shutdowns.
Congress is on a tight schedule to approve federal appropriations bills for FDA and other agencies. It may also take up comprehensive physician payment reform bills that passed out of committees late in 2013; legislation that could have important implications for the device space. Also to look out for: a changing of the guard in the powerful Senate Finance Committee.
Top executives at leading local and foreign drug firms in India by and large earned more in 2020-21, while differentials in CEO to median employee remuneration remained stark. With increasing scrutiny by shareholders and lawmakers, experts suggest that pharma should be more mindful of balancing “adequate” C-suite compensation and glaring inequalities.